A Study on Maternal Immune Responsiveness

Official Title: The MIRACL Study: Maternal Immune Responsiveness as Clinical Target for Preterm Birth Prevention


This study will test new methods of identifying women at risk for preterm birth and predicting response to preventive interventions. We will also examine if and how maternal factors affect immune cells of the mother and baby and determine whether this is important to birth outcomes and outcomes for the baby.

Eligibility criteria:

- Currently more than 17 weeks pregnant
- Pregnant with one baby
- Have had or will have a dating ultrasound

Contact Information

Dr. Shannon Gillespie